arrow
D

Debora Basile

san giovanni di dio hospital
H指数:28
被引数:2,707
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts

基于CD3组织学切片的深度学习预测结肠癌结局:三个国际III期结肠癌队列的分析

2026-05-080
OA
The Current Role of Antiangiogenics in Colorectal Cancer

Basile, D.; Di Nardo, P.; Daffinà, M.G.; Cortese, C.; Giuliani, J.; Aprile, G. 抗血管生成药物在结直肠癌中的当前作用。Int. J. Mol. Sci. 2025, 26, 11605. [Google Scholar] [CrossRef]

2026-03-030
OAAI
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics

激素受体阳性、HER2阴性转移性乳腺癌的纵向表型分析:基于液滴数字PCR的循环肿瘤DNA片段组学研究

2025-07-020
PRE
Advances in Melanoma and Skin Cancers

黑色素瘤和皮肤癌研究进展

2025-02-212
OA
The potential of retinoic acid receptors as prognostic biomarkers and therapeutic targets in gastric cancer

维甲酸受体作为胃癌预后标志物和治疗靶点的潜力

2024-09-110
OAAI
Second-line treatment in older patients with metastatic colorectal cancer: The ELECTRA study

转移性结直肠癌老年患者中的二线治疗:ELECTRA研究

2024-09-010
PRE
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
2024-09-014
OAAI
First-line treatment in older patients with metastatic colorectal cancer: A large real-world study

晚期结直肠癌老年患者的一线治疗:一项大型真实世界研究

2024-09-010
PRE
Prognostic role of macrophage infiltration and monocyte-to-lymphocyte ratio in stage III colon cancer: The MIRROR study

巨噬细胞浸润和单核细胞与淋巴细胞比值在III期结肠癌中的预后作用:MIRROR研究

2024-09-010
PRE
Machine learning evaluation of immune in fi ltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts

通过数字肿瘤评分对免疫功能进行机器学习评估,可以在三个国际III期结肠癌队列的汇总分析中预测生存结果

2024-07-010
OAAI
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts

标准化辅助结肠癌试验中的数据收集: IDEA和ACCENT国际财团和国家专家的共识项目

2024-07-010
OA
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
2024-06-010
PRE
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)

RAS野生型结直肠癌的二线治疗策略: 系统评价和网络荟萃分析 (NMA)

2024-05-012
PRE
Treatment of gastric adenocarcinoma: A rapidly evolving landscape
2023-12-0112
OA
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial
2023-06-012
PRE
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study
2023-03-072
PRE
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment
2022-11-01111
OAAI
Liquid biopsy-based biomarkers for the characterization of hormone receptor-positive (HR+) HER2-Low metastatic breast cancer (mBC)
2022-09-010
OAAI
Investigating the risk of drug-induced interstitial lung disease in patients with metastatic breast cancer treated with antiHER2 regimens through a network meta-analysis approach
2022-09-010
OA
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
2022-06-072
OAAI